This compound is an antiviral pharmaceutical raw material supplied for manufacturing purposes. It consists of a tenofovir alafenamide-like prodrug moiety and fumaric acid forming a salt-like, multi-component structure.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1432630-26-6
Tenofovir isoproxil monoester
Pharmaceutical intermediate for tenofovir prodrug
(((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy)bis(methylene) isopropyl dicarbonate
Pharmaceutical intermediate
((2R,5S)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl 2-hydroxybenzoate
antiviral active pharmaceutical ingredient
Maribavir
antiviral active pharmaceutical ingredient
Baloxavir
antiviral active pharmaceutical ingredient
Favipiravir
antiviral active pharmaceutical ingredient
Eletriptan
active pharmaceutical ingredient
NARATRIPTAN HYDROCHLORIDE
active pharmaceutical ingredient
[[(2S)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid
VCMJCVGFSROFHV-KZHAMYRLSA-N
C[C@@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\C(=O)O